3.237.27.159
dgid:
enl:
npi:0
Journal Scan
Oncology

Population-based BRCA testing could prevent substantial amount of new cancer cases

Posted on

BRCA testing based off of clinical criteria and family history often misses a large number of BRCA carriers who would benefit from screening. Researchers in this study estimated that test the general population of women ≥30 years could prevent an additional 2319 to 2666 breast cancer and 327 to 449 ovarian cancers cases per million women than the current clinical strategy’s.

In addition, population-based testing was found to be cost effective in high-income and upper–middle income countries as well as cost effective for high-income countries health systems from a societal perspective.

Read the full study here.

Reference

Manchanda R, Sun L, Patel S, et al. Economic evaluation of population-based BRCA1/BRCA2 mutation testing across multiple countries and health systems. Cancers. 2020;12(7):1929; https://doi.org/10.3390/cancers12071929.

-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-